Skip to main content
. Author manuscript; available in PMC: 2011 Mar 15.
Published in final edited form as: Clin Cancer Res. 2010 Mar 9;16(6):1884–1893. doi: 10.1158/1078-0432.CCR-09-2636

Table 3.

Multivariate analysis of BMI and OS

All patients (n = 4,366)
Variable HR (95% CI) P*
Categorical BMI (overall) 0.0017
 Underweight vs normal 1.24 (1.03–1.50) 0.0258
 Overweight vs normal 0.90 (0.80–1.00) 0.0500
 Class 1 obese vs normal 1.07 (0.93–1.23) 0.3717
 Class 2,3 obese vs normal 1.19 (0.98–1.45) 0.0805
Age 1.01 (1.01–1.02) <0.0001
Stage (II vs III) 0.47 (0.41–0.53) <0.0001
Treatment (effective vs control/ineffective) 0.72 (0.62–0.85) <0.0001
Gender (men vs women) 1.15 (1.04–1.26) 0.0045

Men (n = 2,268)
Variable HR (95% CI) P*

Categorical BMI (overall) 0.0021
 Underweight vs normal 1.14 (0.81–1.61) 0.4474
 Overweight vs normal 0.82 (0.71–0.95) 0.0063
 Class 1 obese vs normal 0.94 (0.78–1.15) 0.5599
 Class 2,3 obese vs normal 1.35 (1.02–1.79) 0.0391
Age 1.01 (1.01–1.02) <0.0001
Stage (II vs III) 0.51 (0.43–0.61) <0.0001
Treatment (effective vs control/ineffective) 0.64 (0.51–0.80) <0.0001

Women (n = 2,098)
Variable HR (95% CI) P*

Categorical BMI (overall) 0.0674
 Underweight vs normal 1.32 (1.05–1.67) 0.0194
 Overweight vs normal 1.01 (0.85–1.19) 0.9366
 Class 1 obese vs normal 1.24 (1.01–1.53) 0.0447
 Class 2,3 obese vs normal 1.11 (0.84–1.45) 0.4651
Age (1-y increase) 1.01 (1.00–1.02) 0.0052
Stage (II vs III) 0.41 (0.34–0.51) <0.0001
Treatment (effective vs control/ineffective) 0.83 (0.66–1.04) 0.0948
*

Likelihood ratio P value after stratifying by study.

Wald Χ2 P value.